WBH Advisory’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $608K | Hold |
1,722
| – | – | 0.05% | 213 |
|
|
2025
Q4 | $564K | Hold |
1,722
| – | – | 0.04% | 221 |
|
|
2025
Q3 | $486K | Sell |
1,722
-5
| -0.3% | -$1.45K | 0.04% | 239 |
|
|
2025
Q2 | $482K | Sell |
1,727
-52
| -3% | -$14.7K | 0.04% | 227 |
|
|
2025
Q1 | $554K | Sell |
1,779
-27
| -1% | -$7.97K | 0.05% | 196 |
|
|
2024
Q4 | $471K | Sell |
1,806
-37
| -2% | -$11K | 0.04% | 217 |
|
|
2024
Q3 | $594K | Buy |
1,843
+199
| +12% | +$65.1K | 0.06% | 196 |
|
|
2024
Q2 | $514K | Buy |
1,644
+1
| +0.1% | +$294 | 0.05% | 206 |
|
|
2024
Q1 | $467K | Sell |
1,643
-33
| -2% | -$9.66K | 0.05% | 222 |
|
|
2023
Q4 | $483K | Sell |
1,676
-15
| -0.9% | -$4.09K | 0.05% | 212 |
|
|
2023
Q3 | $455K | Buy |
1,691
+14
| +0.8% | +$3.49K | 0.06% | 209 |
|
|
2023
Q2 | $372K | Buy |
1,677
+1
| +0.1% | +$232 | 0.04% | 234 |
|
|
2023
Q1 | $405K | Buy |
+1,676
| New | +$411K | 0.05% | 220 |
|
|
2022
Q3 | $373K | Buy |
1,654
+1
| +0.1% | +$242 | 0.05% | 211 |
|
|
2022
Q2 | $410K | Hold |
1,653
| – | – | 0.05% | 216 |
|
|
2022
Q1 | $394K | Sell |
1,653
-114
| -6% | -$26.2K | 0.05% | 230 |
|
|
2021
Q4 | $397K | Buy |
1,767
+1
| +0.1% | +$211 | 0.05% | 237 |
|
|
2021
Q3 | $375K | Buy |
1,766
+4
| +0.2% | +$921 | 0.05% | 225 |
|
|
2021
Q2 | $432K | Buy |
1,762
+2
| +0.1% | +$492 | 0.06% | 193 |
|
|
2021
Q1 | $438K | Sell |
1,760
-14
| -0.8% | -$3.34K | 0.07% | 191 |
|
|
2020
Q4 | $448K | Buy |
1,774
+22
| +1% | +$5.07K | 0.08% | 180 |
|
|
2020
Q3 | $445K | Buy |
1,752
+33
| +2% | +$8.18K | 0.09% | 166 |
|
|
2020
Q2 | $405K | Buy |
1,719
+2
| +0.1% | +$456 | 0.1% | 164 |
|
|
2020
Q1 | $348 | Buy |
1,717
+2
| +0.1% | +$437 | 0.08% | 161 |
|
|
2019
Q4 | $413K | Sell |
1,715
-24
| -1% | -$5.29K | 0.08% | 168 |
|
|
2019
Q3 | $336K | Buy |
1,739
+2
| +0.1% | +$384 | 0.08% | 179 |
|
|
2019
Q2 | $320K | Buy |
1,737
+1
| +0.1% | +$179 | 0.07% | 187 |
|
|
2019
Q1 | $329K | Buy |
1,736
+2
| +0.1% | +$382 | 0.08% | 184 |
|
|
2018
Q4 | $337 | Buy |
1,734
+1
| +0.1% | +$195 | 0.08% | 178 |
|
|
2018
Q3 | $359K | Buy |
1,733
+2
| +0.1% | +$394 | 0.09% | 185 |
|
|
2018
Q2 | $319K | Buy |
1,731
+1
| +0.1% | +$177 | 0.08% | 183 |
|
|
2018
Q1 | $294K | Buy |
1,730
+1
| +0.1% | +$184 | 0.08% | 193 |
|
|
2017
Q4 | $300K | Buy |
1,729
+2
| +0.1% | +$354 | 0.08% | 189 |
|
|
2017
Q3 | $322K | Buy |
1,727
+1
| +0.1% | +$177 | 0.09% | 180 |
|
|
2017
Q2 | $297K | Buy |
1,726
+2
| +0.1% | +$325 | 0.08% | 188 |
|
|
2017
Q1 | $282K | Buy |
1,724
+1
| +0.1% | +$166 | 0.08% | 190 |
|
|
2016
Q4 | $252K | Buy |
1,723
+1
| +0.1% | +$151 | 0.08% | 195 |
|
|
2016
Q3 | $287K | Buy |
1,722
+1
| +0.1% | +$169 | 0.1% | 177 |
|
|
2016
Q2 | $261K | Buy |
1,721
+1
| +0.1% | +$155 | 0.1% | 163 |
|
|
2016
Q1 | $257K | Buy |
1,720
+2
| +0.1% | +$297 | 0.09% | 167 |
|
|
2015
Q4 | $278 | Buy |
1,718
+1
| +0.1% | +$157 | 0.1% | 160 |
|
|
2015
Q3 | $237K | Buy |
1,717
+1
| +0.1% | +$158 | 0.1% | 164 |
|
|
2015
Q2 | $263K | Buy |
1,716
+1
| +0.1% | +$160 | 0.1% | 168 |
|
|
2015
Q1 | $274 | Buy |
1,715
+29
| +2% | +$4.57K | 0.08% | 170 |
|
|
2014
Q4 | $268K | Hold |
1,686
| – | – | 0.1% | 171 |
|
|
2014
Q3 | $236K | Sell |
1,686
-49
| -3% | -$6.4K | 0.08% | 181 |
|
|
2014
Q2 | $205K | Buy |
1,735
+1
| +0.1% | +$116 | 0.08% | 203 |
|
|
2014
Q1 | $213K | Buy |
+1,734
| New | +$210K | 0.08% | 200 |
|
Other funds holding AMGN
VCM
VPM
WBH Advisory's AMGN Position: Q1 2026 in Review
WBH Advisory held its Amgen (AMGN) position steady in Q1 2026 at 1,722 shares worth $608K. The position accounts for 0.05% of the portfolio, ranked #213.
WBH Advisory first reported a position in AMGN in Q1 2014 and has held it in 48 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- WBH Advisory held 1,722 shares of Amgen worth $608K as of Q1 2026.
- WBH Advisory left its Amgen share count unchanged in Q1 2026.
- Amgen made up 0.05% of WBH Advisory's portfolio in Q1 2026, its #213 holding.
- WBH Advisory first reported a position in Amgen in Q1 2014 and has held it in 48 quarters since.
- 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on WBH Advisory's 13F filing for Q1 2026, filed 27 Apr 2026.